Katherine Stueland Insider Trades & Stock Holdings

CHIEF EXECUTIVE OFFICER · GeneDx Holdings Corp. · Latest filing Jun 16, 2026

Katherine Stueland, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. has 1 Form 4 trade on file since Jun 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($638.09K), net -$638.09K. Latest filing: disposed of 10.50K shares of $WGS on Jun 16, 2026 at $60.76.

Trades on file

1

Open-market bought

$0

Open-market sold

$638.09K

Net open-market

-$638.09K

Latest filing

Jun 16, 2026

All insider trades by Katherine Stueland

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 16, 2026	$WGS	Sell (Open-market sale)	10.50K	$60.76	$638.09K			-4.2%	+1.8%		CHIEF EXECUTIVE OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Katherine Stueland traded

• $WGS

Frequently asked questions

Has Katherine Stueland been buying or selling stock?

Katherine Stueland has 0 open-market purchases and 1 open-market sale on file, net -$638.09K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Katherine Stueland's latest insider trade?

disposed of 10.50K shares of $WGS on Jun 16, 2026 at $60.76.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.